Glenn S. Gerhard

Prof. Glenn S. Gerhard


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2026 in Cells
Verified
Journal Article
Open access
PDF file
FVFNU Vikky
FNU Vikky
ADAasthika Das
Aasthika Das
MBMERIEM BKHACHE
MERIEM BKHACHE
AAAbeer Alshambky
Abeer Alshambky
GGGlenn S. Gerhard
Glenn S. Gerhard
Rihab BoucharebRihab Bouchareb
Rihab Bouchareb
Mitochondria play a central role in numerous physiological and pathological processes, and mitochondrial transplantation is emerging as a promising strategy to restore cellular function and mitigate disease. The success of this approach depends critically on the methods used to isolate, preserve, and retrieve intact, functional mitochondria. Objective: To optimize an isolation strategy that preserves mitochondrial integrity, dynamics, and metabolic activity and to evaluate conditions that enable short-term storage for future organelle biobanking applications. Methods: We compared a mitochondria isolation method developed in our laboratory (Protocol A) with a commercially available kit (Protocol B). Donor mitochondria were isolated from proximal tubular cells and transplanted into HEK293T recipient cells. Mitochondrial functionality was assessed following transfer into HEK293T cells by measuring reactive oxygen species (MitoSOX Red), oxygen consumption rate (OCR) using Seahorse XF analysis, and high-resolution imaging of mitochondrial morphology and dynamics. We further evaluated mitochondrial storage at low temperature and subsequent functional recovery. Results: Protocol A enabled faster isolation (~30 min) than Protocol B (~80 min) and yielded mitochondria with higher transplantation efficiency, greater OCR, preserved dynamic morphology, and lower oxidative stress. Mitochondria isolated using Protocol A remained metabolically active after transplantation and continued to exhibit fission and fusion, whereas those isolated using Protocol B showed reduced dynamic behavior. Importantly, mitochondria isolated with Protocol A retained functional integrity after low-temperature storage, supporting their potential for standardized preservation. Conclusions: This study presents a robust, efficient, and reproducible isolation and frozen-storage protocol that yields highly functional mitochondria suitable for transplantation. The ability to preserve mitochondrial function after storage further highlights the potential for developing organelle biobanks to support future research and therapeutic applications.

6 December 2025 in BMC Genomics
Verified
Journal Article
Open access
PDF file
AAAkshay Anand
Akshay Anand
YAYash Agarwal
Yash Agarwal
TGTanisha Gupta
Tanisha Gupta
JLJason Lin
Jason Lin
MGMirna Ghemrawi
Mirna Ghemrawi
HLHayan Lee
Hayan Lee
Age is a major risk factor for various diseases, such as cancer, cardiovascular conditions, and neurodegenerative diseases. However, chronological age, the simple number of years one has lived, does not capture individual health differences, prompting the development of methods to accurately estimate biological age instead of relying on chronological age. One of the major molecular approaches exploits DNA methylation (DNAm), which is an essential epigenetic modifier for regulating gene expression, cell differentiation, and aging. DNAm-based aging clocks have been developed to predict biological age, but the prediction is highly dependent on training data, including organs and assay technologies. To address these clocks’ high variance, we present two EnsembleAge clocks, leveraging eight previously developed DNAm clocks, harnessing the strengths of each methylome age clock, smoothing out individual variances, and providing a more robust estimation of biological age. We trained our EnsembleAge clock models using DNA methylation data from nine organs in the Genotype-Tissue Expression (GTEx) dataset. Our EnsembleNaive clock model achieved the lowest median absolute error (MeAE) of 4.04 years in whole blood. The EnsembleLR model demonstrated the lowest MeAE of 6.35 years across multiple tissues, including breast, lung, muscle, ovary, prostate, testis, and colon. The significant reduction in MeAE underscores its high practical value in clinical and forensic applications, especially in contexts where epigenetic changes are subtle. We further applied our models to four public datasets representing diverse biological applications, including administered short-term medical opioid use (GSE151485) and long-term opioid overdose (GSE164822). Our model reveals over 10 years of age acceleration in opioid-overdosed brains but no significant epigenetic age acceleration when opioid usage was well administered. Our EnsembleAge clock models are also implemented as a web service, allowing users to conveniently upload their DNA methylation data and receive predictions of their biological age. This empowers individuals to track their biological/epigenetic age over time, mitigating the effect of variance and promoting healthy aging and a beneficial lifestyle. Our EnsembleAge clock service is available at https://ensemble.epiclock.app/ .